Antimicrobial active herbal compounds against Acinetobacter baumannii and other pathogens

Bacterial pathogens cause a number of lethal diseases. Opportunistic bacterial pathogens grouped into ESKAPE pathogens that are linked to the high degree of morbidity, mortality and increased costs as described by Infectious Disease Society of America. Acinetobacter baumannii is one of the ESKAPE pa...

Full description

Bibliographic Details
Main Authors: Vishvanath eTiwari, Ranita eRoy, Monalisa eTiwari
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-06-01
Series:Frontiers in Microbiology
Subjects:
MIC
Online Access:http://journal.frontiersin.org/Journal/10.3389/fmicb.2015.00618/full
id doaj-400a09f68dde4747aed820efa9ec81fc
record_format Article
spelling doaj-400a09f68dde4747aed820efa9ec81fc2020-11-24T23:50:24ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2015-06-01610.3389/fmicb.2015.00618141854Antimicrobial active herbal compounds against Acinetobacter baumannii and other pathogensVishvanath eTiwari0Ranita eRoy1Monalisa eTiwari2Central University of RajasthanCentral University of RajasthanCentral University of RajasthanBacterial pathogens cause a number of lethal diseases. Opportunistic bacterial pathogens grouped into ESKAPE pathogens that are linked to the high degree of morbidity, mortality and increased costs as described by Infectious Disease Society of America. Acinetobacter baumannii is one of the ESKAPE pathogens which cause respiratory infection, pneumonia and urinary tract infections. The prevalence of this pathogen increases gradually in the clinical setup where it can grow on artificial surfaces, utilize ethanol as a carbon source and resists desiccation. Carbapenems, a β-lactam, are the most commonly prescribed drugs against A. baumannii. The high level of acquired and intrinsic carbapenem resistance mechanisms acquired by these bacteria makes their eradication difficult. The pharmaceutical industry has no solution to this problem. Hence, it is an urgent requirement to find a suitable alternative to carbapenem, a commonly prescribed drug for Acinetobacter infection. In order to do this, here we have made an effort to review the active compounds of plants that have potent antibacterial activity against many bacteria including carbapenem resistant strain of A. baumannii. We have also briefly highlighted the separation and identification methods used for these active compounds. This review will help researchers involved in the screening of herbal active compounds that might act as a replacement for carbapenem.http://journal.frontiersin.org/Journal/10.3389/fmicb.2015.00618/fullAcinetobacter baumanniiHerbal MedicineAntibacterial activityMICCarbapenem resistance
collection DOAJ
language English
format Article
sources DOAJ
author Vishvanath eTiwari
Ranita eRoy
Monalisa eTiwari
spellingShingle Vishvanath eTiwari
Ranita eRoy
Monalisa eTiwari
Antimicrobial active herbal compounds against Acinetobacter baumannii and other pathogens
Frontiers in Microbiology
Acinetobacter baumannii
Herbal Medicine
Antibacterial activity
MIC
Carbapenem resistance
author_facet Vishvanath eTiwari
Ranita eRoy
Monalisa eTiwari
author_sort Vishvanath eTiwari
title Antimicrobial active herbal compounds against Acinetobacter baumannii and other pathogens
title_short Antimicrobial active herbal compounds against Acinetobacter baumannii and other pathogens
title_full Antimicrobial active herbal compounds against Acinetobacter baumannii and other pathogens
title_fullStr Antimicrobial active herbal compounds against Acinetobacter baumannii and other pathogens
title_full_unstemmed Antimicrobial active herbal compounds against Acinetobacter baumannii and other pathogens
title_sort antimicrobial active herbal compounds against acinetobacter baumannii and other pathogens
publisher Frontiers Media S.A.
series Frontiers in Microbiology
issn 1664-302X
publishDate 2015-06-01
description Bacterial pathogens cause a number of lethal diseases. Opportunistic bacterial pathogens grouped into ESKAPE pathogens that are linked to the high degree of morbidity, mortality and increased costs as described by Infectious Disease Society of America. Acinetobacter baumannii is one of the ESKAPE pathogens which cause respiratory infection, pneumonia and urinary tract infections. The prevalence of this pathogen increases gradually in the clinical setup where it can grow on artificial surfaces, utilize ethanol as a carbon source and resists desiccation. Carbapenems, a β-lactam, are the most commonly prescribed drugs against A. baumannii. The high level of acquired and intrinsic carbapenem resistance mechanisms acquired by these bacteria makes their eradication difficult. The pharmaceutical industry has no solution to this problem. Hence, it is an urgent requirement to find a suitable alternative to carbapenem, a commonly prescribed drug for Acinetobacter infection. In order to do this, here we have made an effort to review the active compounds of plants that have potent antibacterial activity against many bacteria including carbapenem resistant strain of A. baumannii. We have also briefly highlighted the separation and identification methods used for these active compounds. This review will help researchers involved in the screening of herbal active compounds that might act as a replacement for carbapenem.
topic Acinetobacter baumannii
Herbal Medicine
Antibacterial activity
MIC
Carbapenem resistance
url http://journal.frontiersin.org/Journal/10.3389/fmicb.2015.00618/full
work_keys_str_mv AT vishvanathetiwari antimicrobialactiveherbalcompoundsagainstacinetobacterbaumanniiandotherpathogens
AT ranitaeroy antimicrobialactiveherbalcompoundsagainstacinetobacterbaumanniiandotherpathogens
AT monalisaetiwari antimicrobialactiveherbalcompoundsagainstacinetobacterbaumanniiandotherpathogens
_version_ 1725478622482923520